SAN CARLOS, Calif.--(BUSINESS WIRE)--NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems announced today a system designed to access the critical biological information contained within precious FFPE (formalin-fixed, paraffin-embedded) tissue samples collected and banked through years of clinical studies and cancer research. The NuGEN WT-Ovation™ FFPE System is the first and only whole transcriptome amplification system that generates cDNA for analysis on Affymetrix GeneChip® microarrays and qPCR enabling global gene expression analysis on vast archives of small and degraded samples.
